Nanoscience for Nucleotide Delivery in Diabetes

Abstract

The convergence of nanoscience and nucleotide delivery holds tremendous promise in revolutionizing diabetes treatment. Nucleotide delivery emerged as a promising tool to modulate gene expression and cellular function in diabetes. Integration of nanoscience and nucleotide delivery in diabetes treatment opens avenues for efficient therapies. This approach has the potential to significantly improve glucose regulation and mitigate long-term complications associated with the disease. This chapter discussed DNA and RNA delivery approaches in diabetes treatment and the future and challenges of nucleotide delivery in diabetes.